Position in RIGL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,825,997
+$1,746,738 QoQ
Shares Held
123,364
+8.3% QoQ
Ownership
0.660%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 156 holders
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $9,179,114,031 across 176 Biotechnology names. RIGL ranks #98 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,771,839 | $1,728,352,485 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,347,253 | $1,662,680,977 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,862,503 | $496,766,798 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,040,250 | $491,639,040 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,488,394 | $278,746,426 | |
| 6 | INSM |
INSMED Inc
|
2,273,222 | $242,370,927 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
752,044 | $237,713,585 | |
| 8 | ARGX |
Argenx SE
|
224,930 | $208,683,303 |
All Filings in RIGL
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,825,997 | 123,364 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,079,259 | 113,878 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,757,013 | 41,023 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,036,679 | 36,593 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $456,506 | 24,373 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $436,040 | 24,238 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $366,825 | 21,809 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $206,553 | 12,766 | Shares | Defined | 2024-11-27 | |
| 2024-03-31 | $103,693 | 70,063 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $101,591 | 70,063 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $75,668 | 70,063 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $233,081 | 180,683 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $75,171 | 56,948 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $91,107 | 60,738 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $69,672 | 59,045 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $66,116 | 58,511 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $256,697 | 85,852 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $216,385 | 81,655 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $50,743 | 13,979 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $54,158 | 12,479 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||